Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.
his is not a financial advice!
1 upcoming catalyst on 30rd of June 2024
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Shs. Float of 2.39M Massive Volume recentley - Rel. Vol. of 32.52
Keep an eye on 0.6, 0.85, 1.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.